The Academy of Managed Care Pharmacy (AMCP) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education (CPE).
Pharmacists can earn a maximum of 12.75 contact hours of CPE credit by attending one CPE session during each session block during AMCP Nexus 2019 (not including pre-conference programs and satellite symposia held in conjunction with AMCP Nexus 2019). To obtain credit, pharmacists must attend a session in its entirety, participate in session-specific learning assessments, obtain a session-specific attendance code, complete a session evaluation, and record their participation online at http://amcplearn.org no later than 5:00 PM ET on Monday, December 2, 2019. No exceptions can be made after this date.
Target Audience and Conference Objectives
The CPE sessions at AMCP Nexus 2019 are designed to provide insights and solutions for pharmacists who practice in managed care settings, and to help them maintain and enhance their knowledge, skills, and abilities.
Education sessions available during AMCP Nexus 2019 will deliver timely, practical information in five targeted program tracks:
The Intersection Between Value and Care
How are changing coverage and performance measures affecting patient care? How are the innovative contracts taking health outcomes into account? Find the answers to the questions of the day in this track
Drugs, Diseases and the Managed Care Impact
What in the pipeline is causing us to rethink treatment approaches—and how do we pay for them? This track is your journey into the clinical and managed care universe of new solutions, formulary changes, and evolving strategies for a variety of conditions and treatments.
Legislative and Regulatory Trends: From Rhetoric to Practice
Cut through the noise and find out what will likely impact your work. Health care reform? Drug pricing transparency? What do new initiatives in government mean for patient care? This track is news you can use!
Managed Care Research in Action
What to do with all the facts, figures, studies and surveys? This track helps inform your work with innovative science. Plus, hundreds of poster abstracts to review and discuss in The Exchange!
Specialty Management: Keeping Up with Runaway Innovation
Nowhere will you find more game-changing breakthroughs than in the world of specialty therapeutics. From biosimilars to benefit design, this track shows you how managed care pharmacy is harnessing the revolution by managing drug spend and utilization.
By actively participating in the continuing education programming at AMCP Nexus 2019, managed care pharmacists should be able to:
- Identify the latest trends and innovations in value-based care and the impact on managed care pharmacy.
- Discuss evidence-based approaches and best practices in managing high impact disease states and drugs.
- Summarize the latest legislative and regulatory issues in the health care environment and their impact on managed care pharmacy.
- Outline key findings from cutting-edge managed care research.
- Characterize the rapidly changing specialty pharmaceutical landscape and identify efficient and effective ways to manage this growing market segment.
- Identify challenges and opportunities currently facing managed care pharmacy.
The CPE Monitor system became mandatory for all pharmacists, technicians, and CPE providers on January 1, 2013. If you have not obtained your National Association of Boards of Pharmacy (NABP) e-profile ID, please visit www.nabp.net/programs/cpe-monitor/cpe-monitor-service. If you have any questions about this system or your number, please contact NABP customer support at 847-391-4406, Monday–Friday between 9:00 AM and 5:00 PM CT.
Information about the amount of CPE credit pharmacists earn at AMCP Nexus 2019 is transmitted electronically by AMCP to NABP. Pharmacists who log in to CPE Monitor will be able to access information about CPE credit earned at AMCP Nexus 2019 approximately 72 hours after successful submission.
Some states have special requirements for program content to meet state requirements for continuing education. Please check with your state Board of Pharmacy to determine if such requirements exist and to determine if the CPE sessions at AMCP Nexus 2019 meet those requirements.
Continuing Pharmacy Education Session Types
All continuing education sessions at AMCP Nexus 2019 are knowledge-based (designed primarily for pharmacists to acquire factual knowledge).
Education Session Handouts
Handouts for education sessions will be posted online prior to the start of the conference. Please be aware that handouts will not be distributed in session rooms.
AMCP strives to produce quality educational programming that is free of bias and commercialism. We encourage attendees to convey to AMCP information regarding programming that appears to contain bias or overt commercialism. It is AMCP’s policy to address any issues relating to educational programming content or quality immediately. Should any registrant be dissatisfied with the quality of the continuing education programming offered at an AMCP meeting, a request in writing must be submitted to AMCP within 5 days of the conclusion of the program for consideration of a refund of registration fees.
ACPE has adopted (and requires all accredited CPE providers to abide by) the ACCME Standards for Commercial Support. These standards require that all CPE activities are planned independent of commercial interest and content is delivered with full disclosure and equitable balance.
As an ACPE-accredited provider, AMCP strictly adheres to the ACPE Standards of Commercial Support and other relevant guidelines and standards to ensure the independence of CPE activities. It is AMCP’s intent that all CPE activities be independent, objective, balanced, evidence-based and free of any commercial bias.
All instructional materials for continuing education sessions at AMCP Nexus 2019 undergo an intensive review process to ensure compliance with the Standards for Commercial Support. Disclosures of relevant financial relationships for all parties involved in the planning or delivery of continuing education sessions will appear in the Final Program & Event Guide or be included in slides and announcements at the beginning of each session. AMCP has a mechanism in place for ensuring that any actual conflicts of interest are resolved prior to any continuing education session taking place.
Disclosure of Unlabeled Use
Educational activities may contain discussion of published and/or investigational uses of agents that are not indicated by the Food and Drug Administration. AMCP does not recommend the use of any agent outside of the labeled indications. The opinions expressed in educational activities are those of the faculty and do not necessarily represent the views of AMCP. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in these activities are not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
American with Disabilities Act
AMCP fully intends to comply with the legal requirements of the American with Disabilities Act. If any participant of this conference is in need of accommodation, please do not hesitate to contact AMCP at (703) 684-2600 or visit AMCP registration onsite at the conference.